Observational studyTargeted oncology2023

Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.

Angela DeMichele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.